Candriam SCA’s Puma Biotechnology PBYI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Hold	0	–	-$502K	–	851
2021 Q3	–	Hold	0	–	–	–	782
2020 Q2	–	Sell	-82,200	Closed	-$703K	–	846
2020 Q1	$703K	Hold	82,200	–	–	0.01%	686
2019 Q4	$719K	Sell	82,200 -141,000	-63%	-$1.23M	0.01%	703
2019 Q3	$2.4M	Hold	223,200	–	–	0.03%	457
2019 Q2	$2.82M	Buy	223,200 +208,586	+1,427%	+$2.64M	0.04%	440
2019 Q1	$567K	Sell	14,614 -331,123	-96%	-$12.8M	0.01%	698
2018 Q4	$7.04M	Buy	345,737 +29,537	+9%	+$601K	0.11%	219
2018 Q3	$14.5M	Buy	316,200 +211,200	+201%	+$9.68M	0.19%	124
2018 Q2	$6.21M	Buy	105,000 +37,000	+54%	+$2.19M	0.1%	258
2018 Q1	$4.63M	Buy	68,000 +27,000	+66%	+$1.84M	0.08%	294
2017 Q4	$4.05M	Sell	41,000 -16,500	-29%	-$1.63M	0.07%	310
2017 Q3	$6.89M	Buy	57,500 +8,500	+17%	+$1.02M	0.12%	212
2017 Q2	$4.28M	Sell	49,000 -105,500	-68%	-$9.22M	0.08%	293
2017 Q1	$5.75M	Buy	154,500 +45,000	+41%	+$1.67M	0.11%	221
2016 Q4	$3.36M	Buy	109,500 +41,500	+61%	+$1.27M	0.08%	278
2016 Q3	$4.56M	Sell	68,000 -24,000	-26%	-$1.61M	0.11%	208
2016 Q2	$2.74M	Sell	92,000 -17,000	-16%	-$506K	0.07%	264
2016 Q1	$3.18M	Buy	109,000 +24,700	+29%	+$722K	0.08%	258
2015 Q4	$6.61M	Buy	84,300 +24,000	+40%	+$1.88M	0.18%	141
2015 Q3	$4.54M	Buy	60,300 +31,300	+108%	+$2.36M	0.11%	218
2015 Q2	$3.39M	Buy	29,000 +12,000	+71%	+$1.4M	0.07%	292
2015 Q1	$4.02M	Buy	17,000 +3,000	+21%	+$709K	0.08%	288
2014 Q4	$2.65M	Buy	+14,000	New	+$2.65M	0.06%	323